( MENAFN - ACCESSWIRE) WINSTON-SALEM, NC / ACCESSWIRE / October 23, 2024 / Postbiotics, Inc. and Sabinsa Corporation, announced today a multinational distribution agreement (including the USA, Canada, European Union, and other significant markets (including India and Japan) for the dietary supplement and functional food ingredient PoZibio® for age-related digestive health conditions including Leaky Gut Syndrome (LGS). PoZibio® is a patent-protected postbiotic composition of Lactobacillus paracasei (Patent Number US 11,622,981 B2).
Discovered by gut microbiome longevity researchers at the Wake Forest University College of Medicine, the ingredient is suitable for use in functional foods, medical foods, and dietary supplements due to its low dose, heat stability, and neutral taste profile. Shaheen Majeed, Global CEO & Managing Director of Sabinsa, stated "I'm pleased to bring forth an ingredient for a condition that is very under addressed in the marketplace. Additionally, this marks one of the very first partnerships Sabinsa enters into globally, and at its core represents the best of science and functionality.
" Doug Lynch, Co-founding Partner and Chief Commercial Officer of Postbiotics, Inc. stated "We are pleased to be working with Sabinsa, and believe their global sales organization and manufacturing prowess are perfect complements to our world-class research." Hariom Yadav, PhD.
, Associate Professor of Neurosurgery and Brain Repair and Director of University of South Flor.
